‹ Screener

EDAP TMS SA

FOCL, EDAP · Electromedical & Electrotherapeutic Apparatus · 37.5M shares · EDGAR filings ↗

Reference price $4.22 · est. market cap ~$158M — last insider purchase, 2026-05-11 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

D48

EDAP TMS — French urology/HIFU device maker running losses.

Strengths

Risks

Notable findings

Quarterly revenue

2025-03-31 · $14M2026-03-31 · $18M

Last 2 quarters · from SEC filings.

Key metrics

Gross margin
42.5%
Operating margin
-35.0%
Net margin
-41.5%
Return on equity
-150.7%
Return on assets
-37.0%
ROIC
-55.2%
Revenue growth (QoQ)
24.8%
Debt / equity
0.8×
Current ratio
1.5×
EBITDA
-$21M
Tangible book value
$15M
Cash & investments
$20M

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-05-12Annen StevenGrant90K
2026-05-12Shah SanketGrant68K
2026-05-12Rhodes RyanGrant304K
2026-05-12Mobeck Kenneth S.Grant120K
2026-05-11LEVINE JOSHUABuy10K$4.22

All non-derivative Form 4 activity (SEC), newest first.

Notable events (8-K)

DateItems
2026-06-265.03Shareholder voteExhibitsfiling ↗
2026-06-01Reg FDExhibitsfiling ↗
2026-05-29Otherfiling ↗
2026-05-07ResultsExhibitsfiling ↗
2026-04-02Debt obligation3.02filing ↗
2026-03-25ResultsExhibitsfiling ↗
2026-03-18Reg FDfiling ↗
2026-02-12Exec/director changeReg FDExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-262026-06-260001171843-26-004324 ↗
8-K2026-06-012026-06-010001171843-26-003840 ↗
8-K2026-05-292026-05-290001171843-26-003773 ↗
8-K2026-05-072026-05-070001171843-26-003113 ↗
10-Q2026-05-072026-03-310001104659-26-057094 ↗
8-K2026-04-022026-04-010001171843-26-002218 ↗
10-K2026-03-252025-12-310001104659-26-034528 ↗
8-K2026-03-252026-03-250001171843-26-001889 ↗
8-K2026-03-182026-03-180001171843-26-001688 ↗
8-K2026-02-122026-02-100001171843-26-000769 ↗
8-K2026-01-122026-01-120001171843-26-000204 ↗
20-F2025-03-272024-12-310001558370-25-003828 ↗